Amerigo Scientific Releases Transglutaminase Inhibitors to Unlock Their Therapeutic Potential in Diseases
Amerigo Scientific is excited to announce the release of its transglutaminase inhibitors, designed to advance research into their therapeutic applications across a range of diseases.